David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 5,197 shares at $1.64 ($9K) on 2018-11-15, disclosed to the SEC on 2018-11-19.
Scheduled sale ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.64 | 153 | $251 | 2.9% |
| 2 | $1.64 | 331 | $543 | 6.4% |
| 3 | $1.64 | 4,605 | $8K | 88.6% |
| 4 | $1.63 | 3 | $5 | 0.1% |
| 5 | $1.63 | 7 | $11 | 0.1% |
| 6 | $1.63 | 98 |
| $160 |
| 1.9% |
| Total | $1.64 avg | 5,197 | $9K | 100% |
| Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |
| GEN | SELL | 2018-11-07 | $18K | — | Filing → |